Safety and efficacy of controlled-release oxycodone: A systematic literature review

被引:30
作者
Rischitelli, DG
Karbowicz, SH
机构
[1] Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Dept Pharm Serv, Portland, OR 97201 USA
[3] Regence Bluecross Blueshield, Portland, OR USA
来源
PHARMACOTHERAPY | 2002年 / 22卷 / 07期
关键词
D O I
10.1592/phco.22.11.898.33628
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Prescriptions for controlled-release oxycodone. a narcotic analgesic, recently contributed to a dramatic increase in pharmacy costs for a large private insurance company To determine whether this agent offered clinical benefits over other available drugs that would justify its significantly greater cost, a systematic review of 16 clinical trials was undertaken. The review suggested that immediate-release and controlled-release preparations of oxycodone have similar efficacy and comparable side effect profiles. Controlled-release oxycodone has the advantage of less frequent dosing than immediate-release oxycodone however, other agents may be dosed infrequently at much lower costs. For patients requiring a controlled-release opioid treatment, controlled-release morphine and methadone should be considered because they appear to be as effective as oxycodone and cost considerably less. controlled-release oxycodone may be appropriate for some patients, particularly if they cannot tolerate other controlled-release or long-acting opioid analgesics.
引用
收藏
页码:898 / 904
页数:7
相关论文
共 26 条
  • [1] The rediscovery of methadone for cancer pain management
    Ayonrinde, OT
    Bridge, DT
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (10) : 536 - 540
  • [2] Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain
    Bruera, E
    Belzile, M
    Pituskin, E
    Fainsinger, R
    Darke, A
    Harsanyi, Z
    Babul, N
    Ford, I
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3222 - 3229
  • [3] Caldwell JR, 1999, J RHEUMATOL, V26, P862
  • [4] CARDINALE V, 2001, DRUG TOPICS RED BOOK
  • [5] Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model
    Curtis, GB
    Johnson, GH
    Clark, P
    Taylor, R
    Brown, J
    O'Callaghan, R
    Shi, M
    Lacouture, PG
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (06) : 425 - 429
  • [6] Reduction in constipation and laxative requirements following opioid rotation to methadone: A report of four cases
    Daeninck, PJ
    Bruera, E
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (04) : 303 - 309
  • [7] DEGRAZIA R, 2000, ANN M AM COLL RHEUM
  • [8] Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain
    Gagnon, B
    Bruera, E
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (02) : 120 - 125
  • [9] Methadone: Outpatient titration and monitoring strategies in cancer patients
    Hagen, NA
    Wasylenko, E
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (05) : 369 - 375
  • [10] Hagen NA, 1997, CANCER-AM CANCER SOC, V79, P1428